Close
4

Bora CDMO Bora CDMO

X

CAS 58-27-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 58-27-5
Also known as: 58-27-5, Vitamin k3, 2-methyl-1,4-naphthoquinone, 2-methylnaphthalene-1,4-dione, Menaphthone, Kayquinone
Molecular Formula
C11H8O2
Molecular Weight
172.18  g/mol
InChI Key
MJVAVZPDRWSRRC-UHFFFAOYSA-N
FDA UNII
723JX6CXY5

A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.
1 2D Structure

CAS 58-27-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-methylnaphthalene-1,4-dione
2.1.2 InChI
InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3
2.1.3 InChI Key
MJVAVZPDRWSRRC-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CC1=CC(=O)C2=CC=CC=C2C1=O
2.2 Other Identifiers
2.2.1 UNII
723JX6CXY5
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2-methyl-1,4-naphthalenedione

2. 2-methyl-1,4-naphthoquinone

3. 2-methylnaphthoquinone

4. Bisulfite, Menadione

5. Bisulfite, Menadione Sodium

6. Menadione Bisulfite

7. Menadione Sodium Bisulfite

8. Menadione Sodium Bisulfite, Trihydrate

9. Sodium Bisulfite, Menadione

10. Vicasol

11. Vikasol

12. Vitamin K 3

13. Vitamin K3

14. Vitamin K3 Sodium Bisulfite

2.3.2 Depositor-Supplied Synonyms

1. 58-27-5

2. Vitamin K3

3. 2-methyl-1,4-naphthoquinone

4. 2-methylnaphthalene-1,4-dione

5. Menaphthone

6. Kayquinone

7. 2-methylnaphthoquinone

8. Thyloquinone

9. Kappaxin

10. Kayklot

11. Klottone

12. Kolklot

13. Panosine

14. Kanone

15. 2-methyl-1,4-naphthalenedione

16. Menadion

17. Menaphthon

18. Kipca

19. Prokayvit

20. Aquakay

21. Aquinone

22. Hemodal

23. Kaergona

24. Mitenon

25. Mitenone

26. Karcon

27. Kareon

28. Kativ-g

29. Kaykot

30. Koaxin

31. Synkay

32. K-thrombyl

33. K-vitan

34. Kappaxan

35. Juva-k

36. Vitamin K 3

37. Menaquinone 0

38. 2-methyl-1,4-naphthochinon

39. Vitamin K2(0)

40. Vitamin K0

41. Memodol

42. Usaf Ek-5185

43. 3-methyl-1,4-naphthoquinone

44. Menaphtone

45. 2-methyl-1,4-naftochinon

46. 1,4-naphthalenedione, 2-methyl-

47. 2-methyl-1,4-dihydronaphthalene-1,4-dione

48. Menaphthene

49. Kaynone

50. 1,4-naphthoquinone, 2-methyl-

51. Menadione (vitamin K3)

52. Nsc 4170

53. Ccris 6672

54. Hsdb 3354

55. Menaquinone O

56. Nsc-4170

57. Einecs 200-372-6

58. Unii-723jx6cxy5

59. Mfcd00001681

60. Methyl-1,4-naphthoquinone

61. 723jx6cxy5

62. Dtxsid4021715

63. Mnq

64. 1,4-naphthalenedione, 2-methyl

65. Chebi:28869

66. Ai3-14700

67. Nsc4170

68. Menadione [usp:ban]

69. Chembl590

70. 2-methyl-1,4-naphthalendione

71. Mls000069420

72. Dtxcid801715

73. 1,4-dihydro-2-methylnaphthalene-1,4-dione

74. Menadionum

75. Menadione (vitamin K3) 10 Microg/ml In Acetonitrile

76. Kappaxan (van)

77. Vk3

78. Cas-58-27-5

79. Menadione Semiquinone

80. Ncgc00016258-02

81. Menadione (usp:ban)

82. Smr000059102

83. Menadione (mart.)

84. Menadione [mart.]

85. Menadione (usp-rs)

86. Menadione [usp-rs]

87. Menadione (ep Monograph)

88. Menadione [ep Monograph]

89. Menadione (usp Monograph)

90. Menadione [usp Monograph]

91. 2-methyl-1,4-naftochinon [czech]

92. Menadione (usp)

93. Kappaxin (tn)

94. 2-methyl-1,4-naphthochinon [german]

95. Phytomenadione Impurity A (ep Impurity)

96. Phytomenadione Impurity A [ep Impurity]

97. Sr-01000712386

98. 2-methyl-1,4-naphthodione

99. Methyl-1,4-naphthalenedione

100. Mendione

101. Menadione Phenolic

102. 2-methyl-1,4-naphthoquinone, 5

103. Menadione, 9

104. Menadione,(s)

105. Phytomenadione Imp. A (ep); Menadione; 2-methylnaphthalene-1,4-dione; Phytomenadione Impurity A

106. Menadione1528

107. Prestwick_313

108. Menadione, 98%

109. Menadione, Crystalline

110. Spectrum_001228

111. Specplus_000191

112. Menadione [mi]

113. Menadione [hsdb]

114. Menadione [inci]

115. Opera_id_1802

116. Prestwick0_000459

117. Prestwick1_000459

118. Prestwick2_000459

119. Prestwick3_000459

120. Spectrum2_001194

121. Spectrum4_000722

122. Spectrum5_001764

123. Menadione [vandf]

124. M0373

125. Ncimech_000105

126. Cid_4055

127. Menadione [who-dd]

128. 2-methyl-1,4-napthoquinone

129. Schembl25970

130. Bspbio_000538

131. Kbiogr_000984

132. Kbiogr_002527

133. Kbioss_001708

134. Kbioss_002535

135. 2-methyl-1,4 Naphthoquinone

136. 34524-96-4

137. Mls001148443

138. Bidd:er0556

139. Divk1c_000080

140. Divk1c_006287

141. Spectrum1502254

142. Spbio_001267

143. Spbio_002477

144. 3-methyl-1,4-naphthalenedione

145. Bpbio1_000592

146. Menadione [orange Book]

147. 2-methyl-[1,4]-naphthoquinone

148. Bdbm24778

149. Hms500d22

150. Kbio1_000080

151. Kbio1_001231

152. Kbio2_001708

153. Kbio2_002527

154. Kbio2_004276

155. Kbio2_005095

156. Kbio2_006844

157. Kbio2_007663

158. Kbio3_003005

159. Wln: L66 Bv Evj C1

160. Cmap_000077

161. Ninds_000080

162. Bio1_000471

163. Bio1_000960

164. Bio1_001449

165. Hms1569k20

166. Hms1921p06

167. Hms2092f12

168. Hms2096k20

169. Hms2232a09

170. Hms2234j16

171. Hms3371m08

172. Hms3373a12

173. Hms3655p03

174. Hms3869n03

175. Pharmakon1600-01502254

176. Amy31055

177. Bcp25699

178. Hy-b0332

179. Str01143

180. Tox21_110334

181. Tox21_301367

182. Bbl027351

183. Ccg-35354

184. Menadione (k3), Analytical Standard

185. Nsc758200

186. S1949

187. Stl377874

188. Akos004910447

189. Akos025244105

190. Tox21_110334_1

191. Db00170

192. Fs-2556

193. Nsc-758200

194. Sb17255

195. Idi1_000080

196. Qtl1_000056

197. Usepa/opp Pesticide Code: 006319

198. Ncgc00016258-01

199. Ncgc00016258-03

200. Ncgc00016258-04

201. Ncgc00016258-06

202. Ncgc00016258-07

203. Ncgc00016258-08

204. Ncgc00094978-01

205. Ncgc00094978-02

206. Ncgc00255225-01

207. Ac-34841

208. Nci60_003945

209. Smr000653532

210. Sy018303

211. Sbi-0051776.p002

212. Menadione, Meets Usp Testing Specifications

213. Ft-0612893

214. Ft-0675843

215. Sw219798-1

216. C05377

217. D02335

218. En300-125382

219. A831816

220. Q192471

221. 1,4-naphthalenedione, 2-methyl-, Radical Ion(1-)

222. Q-201350

223. Sr-01000712386-2

224. Sr-01000712386-5

225. Sr-01000712386-6

226. Vitamin K3; 2-methyl-1,4-naphthalenedione

227. Brd-k78126613-001-16-0

228. Vitamin K3; 2-methyl-1,4-naphthoquinone; Menaphthone

229. Vitamin K3: 1,4-dihydro-1,4-dioxo-2-methylnaphthalene

230. Z1255430959

231. Menadione, European Pharmacopoeia (ep) Reference Standard

232. 03aae1e9-b215-45af-976c-91e61894a467

233. Menadione, United States Pharmacopeia (usp) Reference Standard

234. Menadione, Pharmaceutical Secondary Standard; Certified Reference Material

235. Inchi=1/c11h8o2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6h,1h

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 172.18 g/mol
Molecular Formula C11H8O2
XLogP32.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count0
Exact Mass g/mol
Monoisotopic Mass g/mol
Topological Polar Surface Area34.1
Heavy Atom Count13
Formal Charge0
Complexity289
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Therapeutic Uses

The synthetic water soluble forms of vitamin K (menadione, menadiol) have long since been considered inferior to vitamin K1 (phytonadione) in the treatment of drug-induced hypoprothrombinemia.

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1783


Menadione (vitamin K3) a redox cycling quinone, is a clinically important chemotherapeutic agent. ...

PMID:11726226 Laux I, Nel A; Clin Immunol 101 (3): 335-44 (2001)


Menadione, or vitamin K3 (VK3), a potent oxidative stress inducer, has been recently used as an effective and remarkably safe cytotoxic drug for treatment of several human tumors. ...

PMID:10497012 Caricchio R et al; Clinical Immunology 93 (1): 65-74 (1999)


4.2 Drug Warning

... Probably should not be given to newborn infants or women during last few wk of pregnancy.

American Medical Association, Council on Drugs. AMA Drug Evaluations Annual 1994. Chicago, IL: American Medical Association, 1994., p. 795


Menadione is ineffective for the treatment of warfarin and superwarfarin toxicity. It elicits a poor response and should not be used.

Ellenhorn, M.J., S. Schonwald, G. Ordog, J. Wasserberger. Ellenhorn's Medical Toxicology: Diagnosis and Treatment of Human Poisoning. 2nd ed. Baltimore, MD: Williams and Wilkins, 1997., p. 459


Vitamin K /SRP: phytonadione preferred/ must be administered with great care to patients to whom anticoagulants have been given to combat intravascular clotting. ... The vitamin must be "titrated" against the anticoagulant, lest the patient be re-exposed to the same threat of clotting that led to anticoagulants therapy in the first place. No such problem exists in treating persons poisoned accidentally or suicidally by anticoagulant rodenticides. There is no evidence that vitamin K produces in normal persons any excessive tendency of the blood to clot. /vitamin K/

Hayes, W.J., Jr., E.R. Laws Jr., (eds.). Handbook of Pesticide Toxicology Volume 1. General Principles. New York, NY: Academic Press, Inc., 1991., p. 398


Menadione...can induce hemolysis in individuals who are genetically deficient in glucose-6-phosphate dehydrogenase.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1564


For more Drug Warnings (Complete) data for MENADIONE (6 total), please visit the HSDB record page.


4.3 Minimum/Potential Fatal Human Dose

3. 3= Moderately toxic: probable oral lethal dose (human) 0.5-5 g/kg, between 1 oz & 1 pint (or 1 lb) for 70 kg person (150 lb).

Gosselin, R.E., R.P. Smith, H.C. Hodge. Clinical Toxicology of Commercial Products. 5th ed. Baltimore: Williams and Wilkins, 1984., p. II-403


4.4 Drug Indication

The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification.


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Vitamins

Organic substances that are required in small amounts for maintenance and growth, but which cannot be manufactured by the human body. (See all compounds classified as Vitamins.)


Antifibrinolytic Agents

Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. (See all compounds classified as Antifibrinolytic Agents.)


5.2 ATC Code

B - Blood and blood forming organs

B02 - Antihemorrhagics

B02B - Vitamin k and other hemostatics

B02BA - Vitamin k

B02BA02 - Menadione


5.3 Absorption, Distribution and Excretion

Absorption

Variable and ranges from 10% to 80%


Menadione and its water soluble derivatives ... are absorbed even in the absence of bile ... /and/ enter the bloodstream directly.

Gilman, A.G., T.W. Rall, A.S. Nies and P. Taylor (eds.). Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. New York, NY. Pergamon Press, 1990., p. 1565


Eighteen hr after intracardiac admin of (3)H-menadione ... to rats fed diet deficient in vit k, 78% of (3)H had been excreted in urine, 3% in feces, and 29% remained in animals. Biliary excretion ... observed in dogs, & 5-10% of (14)c had been excreted by this route 12 hr after oral dose of (14)C-menadione.

The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 43


Vit k accum in liver, spleen, and lungs. /however/ significant amounts are not stored in body for long periods.

American Medical Association, Council on Drugs. AMA Drug Evaluations Annual 1994. Chicago, IL: American Medical Association, 1994., p. 783


VET: ... Menadione or vit k3 absorbed is converted to k2 for utilization, otherwise it is rapidly eliminated via urine.

Rossoff, I.S. Handbook of Veterinary Drugs. New York: Springer Publishing Company, 1974., p. 659


The pharmacokinetics of menadione (vitamin K3)... were studied in rabbits after iv injection of 75 mg menadiol sodium diphosphate (Synkayvite). ... Plasma clearance was 0.822 L/min. Systemic clearance in RBCs was 0.407 L/min. Apparent volume of distribution was 30.833 L in plasma and 20.488 L in RBCs. Area under the concn-time curve was 32.453 ug min/ml for plasma and 67.219 ug min/ml for RBCs. /Menadiol sodium diphosphate/

PMID:8866040 Hu OY et al; Biopharm. Drug Dispos. 17: 493-499 (1996)


5.4 Metabolism/Metabolites

Hepatic


Distribution studies with menadione tritiated in 6,7-position, ((3)H(6,7))-2-methyl-1,4-naphthaquinone, in rats showed that lipophilic metabolite of menadione, menaquinone-4, 2-methyl-3-geranylgeranyl-1,4-naphthaquinone was present in all tissues examined.

The Chemical Society. Foreign Compound Metabolism in Mammals. Volume 1: A Review of the Literature Published Between 1960 and 1969. London: The Chemical Society, 1970., p. 231


2-methyl-1,4-naphthoquinone yields in rat vit k2(20); yields vit k2(45), and vit k2(50) probably in man. /from table/

Goodwin, B.L. Handbook of Intermediary Metabolism of Aromatic Compounds. New York: Wiley, 1976., p. M-33


...Xenobiotics that are reduced by carbonyl reductases include... menadione... .

Klaassen, C.D. (ed). Casarett and Doull's Toxicology. The Basic Science of Poisons. 6th ed. New York, NY: McGraw-Hill, 2001., p. 145


Menadione is excreted in part as glucuronide and competes with bilirubin for detoxification mechanism of limited capacity in newborn.

Goodman, L.S., and A. Gilman. (eds.) The Pharmacological Basis of Therapeutics. 5th ed. New York: Macmillan Publishing Co., Inc., 1975., p. 1594


For more Metabolism/Metabolites (Complete) data for MENADIONE (6 total), please visit the HSDB record page.


Hepatic


5.5 Biological Half-Life

The pharmacokinetics of menadione (vitamin K3)... were studied in rabbits after iv injection of 75 mg menadiol sodium diphosphate (Synkayvite). Mean elimination half-life of menadione was 27.17 min in plasma and 35.22 min in red blood cells... . /Menadiol sodium diphosphate/

PMID:8866040 Hu OY et al; Biopharm. Drug Dispos. 17: 493-499 (1996)


5.6 Mechanism of Action

Menadione (vitamin K3) is involved as a cofactor in the posttranslational gamma-carboxylation of glutamic acid residues of certain proteins in the body. These proteins include the vitamin K-dependent coagulation factors II (prothrombin), VII (proconvertin), IX (Christmas factor), X (Stuart factor), protein C, protein S, protein Zv and a growth-arrest-specific factor (Gas6). In contrast to the other vitamin K-dependent proteins in the blood coagulation cascade, protein C and protein S serve anticoagulant roles. The two vitamin K-dependent proteins found in bone are osteocalcin, also known as bone G1a (gamma-carboxyglutamate) protein or BGP, and the matrix G1a protein or MGP. Gamma-carboxylation is catalyzed by the vitamin K-dependent gamma-carboxylases. The reduced form of vitamin K, vitamin K hydroquinone, is the actual cofactor for the gamma-carboxylases. Proteins containing gamma-carboxyglutamate are called G1a proteins.


The vitamin K-dependent blood clotting factors, in the absence of vitamin K (or in the presence of the coumarin type of anticoagulant), are biologically inactive precursor proteins in the liver. Vitamin K functions as an essential cofactor for a microsomal enzyme system that activates these precursors by the conversion of multiple residues of glutamic acid near the amino terminus of each precursor to gamma-carboxyglutamyl residues in the completed protein. The formation of this new amino acid, gamma-carboxyglutamic acid, allows the protein to bind Ca+2 and in turn to be bound to a phospholipid surface, both of which are necessary in the cascade of events that lead to clot formation. /Vitamin K/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1783


Vitamin k is necessary for formation of prothrombinogen and other blood clotting factors in liver. During clotting, circulating prothrombin is required for production of thrombin; in turn, thrombin converts fibrinogen to fibrin, network of which constitutes clot. /vitamin k/

Osol, A. and J.E. Hoover, et al. (eds.). Remington's Pharmaceutical Sciences. 15th ed. Easton, Pennsylvania: Mack Publishing Co., 1975., p. 943


The active form of vitamin K appears to be the reduced vitamin K hydroquinone, which, in the presence of oxygen, carbon dioxide, and the microsomal carboxylase enzyme, is converted to its 2,3-epoxide at the same time gamma-carboxylation takes place. The hydroquinone form of vitamin K is regenerated from the 2,3-epoxide by a coumarin sensitive epoxide reductase ... . /Vitamin K/

Hardman, J.G., L.E. Limbird, P.B., A.G. Gilman. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill, 2001., p. 1784


Menadione is a potent inhibitor of aldehyde oxidase (Ki ~0.1 uM) and can be used together with allopurinol to discriminate between aldehyde oxidase- and xanthine oxidase-catalyzed reactions.

Klaassen, C.D. (ed). Casarett and Doull's Toxicology. The Basic Science of Poisons. 6th ed. New York, NY: McGraw-Hill, 2001., p. 160


For more Mechanism of Action (Complete) data for MENADIONE (6 total), please visit the HSDB record page.


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY